Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential - Quiz - MDSpire

Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential

  • By

  • Michael Colwill

  • Sebastian Povlsen

  • Richard Pollok

  • Kamal Patel

  • James Goodhand

  • Tariq Ahmad

  • Sailish Honap

  • September 16, 2025

  • 0 min

Share

Original Source(s)

Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential

  • by Michael Colwill, Sebastian Povlsen, Richard Pollok, Kamal Patel, James Goodhand, Tariq Ahmad, Sailish Honap

  • September 16, 2025

Related Content

The role of the complement system in gastrointestinal-related diseases

Retraction Note: Intrathoracic Migration of Gastric Sleeve Affects Weight Loss as well as GERD–an Analysis of Remnant Gastric Morphology for 100 Patients at One Year After Laparoscopic Sleeve Gastrectomy

Gut microbiota and pediatric metabolic dysfunction–associated steatotic liver disease: clinical evidence and therapeutic implications